glutamic acid and Bone Loss, Osteoclastic
glutamic acid has been researched along with Bone Loss, Osteoclastic in 9 studies
Research
Studies (9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Furusawa, K; Kobayashi, Y; Mizoguchi, T; Nakamichi, Y; Naramoto, H; Takahashi, M; Takahashi, N; Udagawa, N; Uehara, S; Uematsu, T; Yamaoka, M; Yamashita, T; Yang, S | 1 |
Alstergren, P; Bratt, J; Hajati, AK; Kopp, S; Näsström, K | 2 |
Seidlitz, EP; Sharma, MK; Singh, G | 1 |
Echigo, N; Edwards, RH; Hayashi, M; Hua, Z; Juge, N; Mizoguchi, T; Morimoto, R; Moriyama, Y; Ninomiya, T; Omote, H; Senoh, S; Udagawa, N; Uehara, S; Yamamoto, A; Yatsushiro, S | 1 |
Gorski, JP | 1 |
Grabowski, PS; Laketic-Ljubojevic, I; Peet, NM; Skerry, TM | 1 |
Arora, M; Attwell, D; Boyde, A; Gray, C; Jones, S; Marie, H; Tanaka, K | 1 |
Chenu, C; Espinosa, L; Itzstein, C | 1 |
Reviews
1 review(s) available for glutamic acid and Bone Loss, Osteoclastic
Article | Year |
---|---|
Is all bone the same? Distinctive distributions and properties of non-collagenous matrix proteins in lamellar vs. woven bone imply the existence of different underlying osteogenic mechanisms.
Topics: 1-Carboxyglutamic Acid; Aspartic Acid; Biomechanical Phenomena; Bone and Bones; Bone Diseases; Bone Matrix; Bone Resorption; Chromosome Mapping; Endoplasmic Reticulum; Extracellular Matrix Proteins; Glutamic Acid; Glycoproteins; Humans; Integrin-Binding Sialoprotein; Osteocalcin; Osteoclasts; Osteogenesis; Parathyroid Hormone; Phosphoproteins; Proteins; Sarcoplasmic Reticulum; Serine; Sialoglycoproteins; Time Factors; Tooth | 1998 |
Other Studies
8 other study(ies) available for glutamic acid and Bone Loss, Osteoclastic
Article | Year |
---|---|
Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners.
Topics: Actins; Animals; Antineoplastic Agents; Bone and Bones; Bone Marrow Cells; Bone Resorption; Calcitriol; Cell Survival; Cells, Cultured; Coculture Techniques; Dinoprostone; Docetaxel; Glutamic Acid; Humans; Macrophages; Male; Mice; Osteoblasts; Osteoclasts; Paclitaxel; RANK Ligand; Taxoids | 2009 |
Endogenous glutamate in association with inflammatory and hormonal factors modulates bone tissue resorption of the temporomandibular joint in patients with early rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Blood Sedimentation; Bone Resorption; C-Reactive Protein; Cone-Beam Computed Tomography; Estradiol; Female; Glutamic Acid; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Rheumatoid Factor; Sex Factors; Temporomandibular Joint; Temporomandibular Joint Disorders; Testosterone | 2009 |
Temporomandibular joint bone tissue resorption in patients with early rheumatoid arthritis can be predicted by joint crepitus and plasma glutamate level.
Topics: Adult; Aged; Arthritis, Rheumatoid; Biomarkers; Bone Resorption; Female; Glutamic Acid; Humans; Inflammation Mediators; Joint Diseases; Male; Middle Aged; Radiography; Serotonin; Temporomandibular Joint | 2010 |
Extracellular glutamate alters mature osteoclast and osteoblast functions.
Topics: Alkaline Phosphatase; Amino Acid Transport System y+; Animals; Bone and Bones; Bone Resorption; Calcification, Physiologic; Cattle; Cell Communication; Cell Differentiation; Cell Line; Cell Line, Transformed; Cell Proliferation; Cell Survival; Glutamic Acid; Humans; Macrophages; Mice; Osteoblasts; Osteoclasts; Receptors, N-Methyl-D-Aspartate | 2010 |
Secretion of L-glutamate from osteoclasts through transcytosis.
Topics: 3T3 Cells; Animals; Bone Resorption; Cell Line; Cells, Cultured; Exocytosis; Glutamic Acid; Homeostasis; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Immunoelectron; Models, Biological; Osteoclasts; Receptors, Metabotropic Glutamate; Signal Transduction; Vesicular Glutamate Transport Protein 1 | 2006 |
The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.
Topics: Actins; Animals; Bone Resorption; Cell Differentiation; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Ligands; Mice; N-Methylaspartate; Osteoclasts; Patch-Clamp Techniques; Rabbits; Rats; Receptors, N-Methyl-D-Aspartate | 1999 |
Glutamate does not play a major role in controlling bone growth.
Topics: 2-Amino-5-phosphonovalerate; Alveolar Bone Loss; Amino Acid Transport System X-AG; Animals; Animals, Newborn; ATP-Binding Cassette Transporters; Biological Transport; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Cells, Cultured; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Femur; Glutamic Acid; Glycine; Humerus; Mandible; Mice; Mice, Knockout; Models, Animal; N-Methylaspartate; Osteoblasts; Osteoclasts; Osteogenesis; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2001 |
Absence of evidence is not evidence of absence. Redundancy blocks determination of cause and effect.
Topics: 2-Amino-5-phosphonovalerate; Amino Acid Transport System X-AG; Animals; Bone Resorption; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; N-Methylaspartate; Osteoblasts; Osteogenesis; Receptors, N-Methyl-D-Aspartate | 2001 |